RxDoctor Payments Data

Collette Ngante

Psychiatric/Mental Health · Fredericksburg, VANPI 1619331204

Payments from drug & device makers

$6,276in general payments, 2019–2025

Across 360 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Otsuka America Pharmaceutical, Inc.$994
  • Lundbeck LLC$922
  • AbbVie$836
  • Alkermes, Inc.$424
  • Johnson & Johnson$318
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$6,21599%
  • Education$611%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,276 in reported general payments places this provider in the 90th percentile of 1,003 psychiatric/mental health providers in Virginia.

See all psychiatric/mental health providers in Virginia

Medicare billing

Part B allowed, 2024
$217,552
Medicare patients
302
Services billed
2,213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole45$3,861
Duloxetine Hcl17$1,018
Quetiapine Fumarate73$907
Haloperidol24$672
Sertraline Hcl63$621
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine22$585
Paroxetine Hcl16$457
Buspirone Hcl16$421
Venlafaxine Hcl ErVenlafaxine Hcl37$413
Hydroxyzine Hcl19$383
Bupropion XlBupropion Hcl20$374
Clozapine20$367
Alprazolam91$314
Clonazepam89$284
Lamotrigine42$272

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCOlanzapine$14$17418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,003 psychiatric/mental health providers in Virginia.

Other psychiatric/mental health in Fredericksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →